Vitamin receptor drug delivery conjugates for treating inflammation
US10500204B2 · kind B2 · utility
0Cited by
136References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 13, 2017 |
| Grant date | Dec 10, 2019 |
| Priority date | — |
| Expiry date | Nov 13, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K7/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are compositions, methods, compounds, conjugates, and kits for use in targeted drug delivery using drug delivery conjugates containing hydrophilic spacer linkers for use in treating disease states caused by pathogenic cell populations, such as inflammatory cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.